Caren van Roekel

68 Chapter 2 Radioembolization is a safe and effective treatment and currently mainly indicated in a palliative setting for unresectable, chemorefractory primary and secondary hepatic malignancies. Side effects of radioembolization are usually mild and self-limiting. Within nuclear medicine and interventional oncology, radioembolization is a fast developing field of expertise. ABBREVIATIONS 18 F-FDG  fluor-18 fluorodeoxyglucose 68 Ga  gallium-68 89 Y  yttrium-89 90 Y  yttrium-90 90 Sr  strontium-90 90 Zr  zirconium-90 99m Tc-MAA  99m Technetium macro-accregated albumin 166 Ho  holmium-166 ADC  apparent diffusion coefficient AE  adverse event BED ave biologically effective dose averaged over voxel values BCLC  Barcelona Clinic Liver Cancer Bq  Becquerel BSA  body surface area CA  cystic artery CBCT  C-arm cone beam CT CEA  carcinoembryonic antigen CHA  common hepatic artery CMR  complete metabolic response CT  computed tomography D  mean absorbed dose DEB-TACE  chemoembolization with drug-eluting beads DCE  dynamic contrast-enhanced dPET  digital photon counting PET DSA  digital subtraction angiography